Global Plasma Fractionation Market is growing with factors such as rise in respiratory diseases across the world, increase in aging population with blood-related ailments and increasing usage of immunoglobulins. Increase in rare diseases that require the use of plasma therapy or plasma derivatives also acts as a major factor for the growth of the market. Increasing investment in research and development has also given a boom to the global plasma fractionation market.
Increase in the number of plasma collection centres, has propelled the demand of the market. However, growing usage of recombinant protein products and stringent government regulations regarding plasma therapy, have decreased the demand of the market.
Global Plasma Fractionation Market Scenario
According to Data Bridge Market Research, the market for global plasma fractionation in North America has the highest market share followed by Europe and Asia-Pacific. Market leader is CSL Plasma which accounts an estimated market share of approximately 28.09% in the global plasma fractionation market. The company has gained outstanding sale by providing novel rehabilitation therapy services. For instance,
- In May, 2021 CSL Pharma and The Colorado Cross-Disability Coalition formed an agreement to expand opportunities for people with disabilities to donate plasma. This will help the company enhance its ability to provide plasma to treat individuals suffering from serious diseases.
Trends Impacting the Market
Now the question is which other regions CSL Plasma, Grifols S.A. and Octapharma AG are targeting? Data Bridge Market Research has forecasted a large growth in North America plasma fractionation market and the market leaders targeting U.S. and Canada to be their next pocket revenue for 2021.
The global plasma fractionation market is becoming more competitive with companies like CSL Plasma, Grifols S.A. and Octapharma AG. These are the top dominating companies in plasma fractionation market and have launched novel products in the market. The data bridge market research new reports highlight the major growth factors and opportunities in the global plasma fractionation market.
For more analysis on the global plasma fractionation market request for a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-plasma-fractionational-market
New Market Developments 2021
- In April 2021, CSL Pharma and BOCA RATON, Terumo Blood and Cell Technologies announced a collaboration to provide a new plasma collection platform at CSL Plasma U.S. collection centers. This will help the company to serve patients a more significant platform that requires plasma for therapeutic purposes.
In April 2021, Grifols, S.A signed an agreement with the government of Andorra to develop a global R+D+i hub to develop advanced knowledge of the human immune system to investigate and develop new immune therapies. This will help the company to develop a treatment for immune system disorders through translational and clinical expertise.
Scope of Plasma Fractionation Market
All country based analysis of the global plasma fractionation market is further analysed based on maximum granularity into further segmentation. On the basis of product type, the global plasma fractionation market is segmented into immunoglobulins, coagulation factor concentrates, albumin, protease inhibitors, and other products. On the basis of application, the global plasma fractionation market is segmented into immunology, haematology, critical care, neurology, pulmonology, haemato-oncology, rheumatology, and other application. On the basis of processing technology, the global plasma fractionation market is segmented into ion-exchange chromatography, affinity chromatography, ultrafiltration, microfiltration, and cryoprecipitation. On the basis of mode, global plasma fractionation market is segmented into modern plasma fractionation, traditional plasma fractionation. On the basis of end user, the global plasma fractionation market is segmented into hospitals & clinics, clinical research laboratories, academic institutes, and others. On the basis of distribution channel, the global plasma fractionation market is segmented into direct tenders, third party distribution, and others.
To know more about the study https://www.databridgemarketresearch.com/reports/global-plasma-fractionational-market
Key Pointers Covered in Global Plasma Fractionation Market Industry Trends and Forecast to 2028
- Market Size
- Top to Bottom Market Analysis
- Recent Developments for Market competitors
- Recent Market Value for Different Countries
- Market value and overview of Plasma fractionation market
- Company profiling of top twenty five players of Plasma fractionation market
Key Market Competitors Covered in the Report
- CSL Plasma
- Grifols S.A.
- Octapharma AG
- Kendrion S.p.A
- Takeda Pharmaceutical Company Limited.
- Baxter
- ADMA Biologics Inc.
- Bharat Serums and Vaccines Limited (BSV)
- Bio Products laboratory Ltd.
- Biotest AG
- Boccard
- Centurion
- China Biologic Products Holdings, Inc.
- Green Cross Corp
- Intas Pharmaceuticals Ltd
- Japan Blood Products Organization
- Kabafusion
- LFB S.A.
- Merck KGaA
- Novasep
- Pall Corporation
- Sanquin
- Shanghai RAAS
- Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
- SK plasma
Above are the key players covered in the report, to know about more and exhaustive list of plasma fractionation companies, contact us https://www.databridgemarketresearch.com/toc/?dbmr=global-plasma-fractionational-market
Research Methodology: Global Plasma Fractionation Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Primary Respondents
- Demand side: Manufacturer, Healthcare industry, Scientists, Research Laboratories
- Supply Side: Product Managers, Marketing Managers, C-Level executives, Distributors, Market Intelligence and Regulatory Affairs Managers among others.
Related Reports
- Global Blood Plasma Market – Industry Trends and Forecast to 2027
- Global Cold Plasma Market – Industry Trends and Forecast to 2027
- Global Plasma Feed Market – Industry Trends and Forecast to 2028
Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/
